Screening recommendations, preventive care guidance, and updates from expert panels and agencies.
CDC now recommends one RSV dose for adults 75 and older, and for adults 50 to 74 who are at increased risk of severe RSV illness. Here’s what changed, who may qualify, when vaccination makes the most sense, and what has not changed.
New CDC and USPSTF guidance is a reminder that sexual-health screening is part of routine preventive care, not just care after symptoms or a known exposure. For many adults, adolescents, and pregnant people, the key questions are when to test, how often to repeat testing, and which infections should be included.
Average-risk adults in the United States should start colorectal cancer screening at 45, not 50. The test may be a stool test, a colonoscopy, or another approved option — but any abnormal stool or imaging result still needs a colonoscopy to finish the screening process.
The current U.S. recommendation for many average-risk women is a mammogram every two years from ages 40 to 74. People at higher risk may need a different plan, so it is worth checking your own risk factors and asking a clinician if your screening schedule should be adjusted.
New CDC and CMS guidance keeps colorectal cancer screening front and center for adults ages 45 to 75. The main message is simple: screening is for people who do not have symptoms, and the right test depends on age, risk, access, and follow-up needs.
CDC recommends a one-time hepatitis B screening for all adults age 18 and older, using three blood tests together. The goal is to find hidden infection early, identify who is immune, and connect people to vaccination or care when needed.
The U.S. Preventive Services Task Force says clinicians should screen women of reproductive age, including pregnant and postpartum patients, for intimate partner violence. The same update says evidence is still insufficient to recommend routine screening for caregiver abuse in older or vulnerable adults.
The American College of Physicians now says routine mammograms can start at 50 for average-risk women, but current federal task force guidance still says start at 40. Here is what changed on April 17, 2026, who is affected, and what questions to ask before your next screening.
Self-collected HPV testing is now an option in U.S. guidance for some average-risk adults ages 30 to 65, but it is not a universal replacement for Pap tests or follow-up care.
ACOG has updated its cervical cancer screening guidance to include a patient-collected sample option for high-risk HPV testing in some average-risk adults ages 30 to 65. The change may help people who have had trouble getting screened, but it does not replace follow-up care or every other screening approach.
New 2026 guidance adds self-collected high-risk HPV testing as a screening option for some average-risk adults ages 30 to 65. The change could make cervical cancer screening easier for people who face time, comfort, or access barriers, but clinics still need the right workflow and follow-up system in place.
CDC guidance now recommends a single RSV vaccine dose for all adults 75 and older and for adults 50 to 74 who are at increased risk of severe RSV illness. For many families, the practical question is whether age and medical history put someone in a group that should ask about vaccination before next winter.
Walking getting slower or more uncomfortable? Peripheral artery disease can limit mobility even without classic calf pain, especially with vascular risks.
Updated CDC pages show fall deaths are still rising in older adults. Here’s how fall prevention, bone health, screening, and Medicare coverage connect.
A new U.S. cholesterol guideline adds more emphasis to one-time lipoprotein(a) testing. Here’s who may want to ask and what the result can mean.
A January 2026 federal update makes HPV-only screening the preferred option for many women 30 to 65 and adds self-collection as a choice.
New U.S. guidance says women 65 and older should be screened for osteoporosis, and some younger postmenopausal women should be screened sooner.
Blood in the urine is not always cancer, but new research suggests delayed follow-up is common. Here’s what hematuria means and when prompt care matters.
An oral cancer screening during a dental visit is usually a simple look-and-feel exam of the mouth, throat area, and neck. It can help spot suspicious changes early, even though current evidence still does not prove that screening symptom-free adults lowers deaths.
A new March 3, 2026 modeling study suggests breast MRI may make the most sense for people with extremely dense breasts plus higher-than-average breast cancer risk. A dense-breast notice alone does not automatically mean you need an MRI.
A new U.S. cholesterol guideline says some adults may need risk discussions earlier, including one-time lipoprotein(a) testing and, in select cases, treatment decisions before age 40.
New 2026 U.S. colorectal cancer statistics show a split trend: rates keep falling in many older adults but are rising in younger adults. Here is what that means for symptoms, screening at 45, family history, and why access still matters.
End of content
End of content
